Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Glucagon antagonists/inverse agonists

Glucagon antagonists/inverse agonists

US Patent 6953812 · Granted Oct 11, 2005

Estimated economic value: $3,855,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glucose-sensitive albumin-binding derivatives2025
Insulin analogues and uses thereof2024
Insulin analogues and uses thereof2024
CNP compounds2024
Glucose-sensitive albumin-binding derivatives2023
Bifunctional compounds comprising insulin peptides and EGF(A) peptides2023
Insulin analogues and uses thereof2022
Oligomer extended insulin-Fc conjugates2022
Oligomer extended insulin-Fc conjugates2022
Insulin derivatives and the medical uses hereof2022
Glucose-sensitive albumin-binding derivatives2021
GLP-1 derivatives and uses thereof2021